Schwendenman Andrew sold REPL
April 1, 2026 · Form 4 insider transaction
Schwendenman Andrew sold 36,667 shares of Replimune Group, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 6 days after the transaction.
Direction
Disposed (sell-side)
Shares
36,667
Price
$0.00
Total value
N/A
InsiderSchwendenman Andrew
Role—
CompanyReplimune Group, Inc. (REPL)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateApril 1, 2026
Filing dateApril 7, 2026
Shares owned after114,951
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2027 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2030, subject to the Reporting Person's continuous service to the Issuer.